ReviewMedicine2019

Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review.

Wei-Xun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.